VHOSPITAL.CLINIC · Drug Reference
Rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination antiretroviral therapy for HIV-1 infection.
Antivirals target virus-specific proteins or processes to inhibit viral replication. Different antivirals are specific to different viral families and cannot be used interchangeably across viral infections.
Used to treat viral infections including herpes, influenza, HIV, hepatitis B and C, and cytomegalovirus. Effectiveness depends on early initiation for most acute viral infections.
Antivirals work best when started early in the course of infection. For chronic viral infections (HIV, hepatitis), adherence is critical to prevent resistance.
Efavirenz
Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination antiretroviral therapy for HIV-1 infection.
Nevirapine
Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination antiretroviral therapy for HIV-1 infection.
Doravirine
Doravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination antiretroviral therapy for HIV-1 infection.
Describe your symptoms and concerns and get a structured clinical assessment — possible causes, red flags, and recommended next steps.
Start Free AI Analysis →Medical Disclaimer: This drug reference is provided for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or qualified health provider before starting, stopping, or changing any medication. Information reviewed by the vHospital Editorial Team · Sources: WHO, BNF, FDA prescribing information, UpToDate.